Catherine Pearce Cin Cor Pharma, Inc. (CINC) insider trading activity

CINC Quotes by TradingView

Catherine Pearce is Chief Operating Officer of CinCor Pharma, Inc.. Currently has a direct ownership of 0 shares of CINC, which is worth approximately $0. The most recent transaction as insider was on Feb 24, 2023, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Catherine Pearce Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2023
SELL
Sale (or disposition) back to the issuer
-
15,000 Reduced 100.0%
0 Common Stock
Feb 24 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
140,149 Reduced 90.33%
15,000 Common Stock
Jan 26 2023
BUY
Grant, award, or other acquisition
-
15,000 Added 8.82%
155,149 Common Stock
Jan 11 2023
SELL
Payment of exercise price or tax liability
$114,913 $28.75 p/Share
3,997 Reduced 2.77%
140,149 Common Stock
Jan 11 2023
BUY
Exercise of conversion of derivative security
-
13,235 Added 8.41%
144,146 Common Stock
Jan 11 2022
BUY
Open market or private purchase
$12,000 $16.0 p/Share
750 Added 0.57%
130,911 Common Stock
CP

Catherine Pearce

Chief Operating Officer
Boston, MA

Track Institutional and Insider Activities on CINC

Follow CinCor Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CINC shares.

Notify only if

Insider Trading

Get notified when an Cin Cor Pharma, Inc. insider buys or sells CINC shares.

Notify only if

News

Receive news related to CinCor Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CINC